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Abstract The Escherichia coli host system is an advanta-
geous choice for simple and inexpensive recombinant pro-
tein production but it still presents bottlenecks at expressing
soluble proteins from other organisms. Several efforts have
been taken to overcome E. coli limitations, including the
use of fusion partners that improve protein expression
and solubility. New fusion technologies are emerging to
complement the traditional solutions. This work evaluates
two novel fusion partners, the Fh8 tag (8 kDa) and the H tag
(1 kDa), as solubility enhancing tags in E. coli and their
comparison to commonly used fusion partners. A broad
range comparison was conducted in a small-scale screening
and subsequently scaled-up. Six difficult-to-express target
proteins (RVS167, SPO14, YPK1, YPK2, Frutalin and
CP12) were fused to eight fusion tags (His, Trx, GST,
MBP, NusA, SUMO, H and Fh8). The resulting protein
expression and solubility levels were evaluated by sodium
dodecyl sulfate polyacrylamide gel electrophoresis before
and after protein purification and after tag removal. The Fh8
partner improved protein expression and solubility as the
well-known Trx, NusA or MBP fusion partners. The H
partner did not function as a solubility tag. Cleaved proteins
from Fh8 fusions were soluble and obtained in similar or
higher amounts than proteins from the cleavage of other
partners as Trx, NusA or MBP. The Fh8 fusion tag therefore
acts as an effective solubility enhancer, and its low molec-
ular weight potentially gives it an advantage over larger
solubility tags by offering a more reliable assessment of
the target protein solubility when expressed as a fusion
protein.
Keywords Escherichia coli . Fusion protein . Fh8 fusion
tag . Traditionally used fusion tags . Protein solubility . Tag
removal
Introduction
The production of soluble and functional protein in
Escherichia coli is still a major challenge in biotechnology
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research. In spite of its fast growth, low cost, high productiv-
ity, and extensive genetic characterization,E. coli occasionally
still suffers from low expression and/or low solubility of target
proteins (Demain and Vaishnav 2009; Makino et al. 2011; Peti
and Page 2007; Terpe 2006). Several efforts have been
exploited to prevent recombinant protein aggregation and to
improve its soluble production by the use of different pro-
moters, expression strains and induction conditions,
co-expression of chaperones, and soluble fusion partners
(Berrow et al. 2006; Makino et al. 2011; Pacheco et al.
2012; Sorensen and Mortensen 2005; Studier 2005; Vernet
et al. 2011). The fusion of a highly soluble carrier to recom-
binant proteins has been generally used to improve protein
solubility and expression in E. coli (Esposito and Chatterjee
2006; Ohana et al. 2009; Terpe 2003;Waugh 2005)), although
success is not yet always guaranteed. The Trx (LaVallie et al.
2000), GST (Smith 2000; Smith and Johnson 1988), MBP
(Kapust and Waugh 1999; Sachdev and Chirgwin 2000), and
NusA (Davis et al. 1999; De Marco et al. 2004) fusion
partners are commonly employed as solubility enhancing
carriers, but when producing a recombinant protein for struc-
tural and functional applications, these fusion partners must
often be removed. The removal of fusion partners is usually
made by specific protease sites included between the fusion
tag and the target protein. However, after cleavage of the
soluble fusion partner, precipitation of the target proteins can
occur. Here, a major bottleneck appears as the target protein
solubility can dramatically change in the presence and absence
of the fusion partner. Meanwhile, new fusion solutions
are constantly emerging and complementing the other
fusion partners, as for instance, SUMO fusion technology
(Marblestone et al. 2006; Malakhov et al. 2004). A novel
fusion system (Hitag®) is presented in this work: the Fh8
and H partners. The Fh8 fusion partner is an 8-kDa calcium-
binding recombinant protein (GenBank ID AF213970)
extracted from the parasite Fasciola hepatica, and it has been
previously used on the diagnosis of parasite infections (Silva
et al. 2004). The recombinant Fh8 was also studied before by
directed mutagenesis, in which its N-terminal sequence
revealed to be important for Fh8 stability and production in
E. coli (not published). From this analysis, a new fusion
partner was suggested: the H tag that corresponds to the first
eleven aminoacids of the Fh8 N-terminus, resulting in a mo-
lecular weight of 1 kDa. In this work, both Fh8 and H fusion
partners are explored as solubility enhancing partners and
compared to the commonly used fusion partners Trx, GST,
MBP, NusA, and SUMO. The study conducted here does not
only evaluate the novel fusion system effect on protein solu-
bility but also the behavior of target proteins after Fh8 and H
tags removal in comparison to the other fusion partners. Six
difficult-to-express target proteins in E. coli were fused to
eight fusion tags and the resulting solubility compared in a
broad screening before and after tag removal.
Materials and methods
General
In this work, all the cloning PCRs used the Phusion High-
Fidelity DNA Polymerase (New England Biolabs) with an
annealing temperature of 55 °C, according to the manufac-
turer’s instructions. The colony PCRs were conducted using
the in-house DNATaq Polymerase with an annealing temper-
ature of 55 °C and with the T7 forward and reverse universal
primers. Plasmid DNA extractions were performed using the
QIAGEN kits for maxi- and minipreps and the QIAquick
DNA gel extraction kit or QIAquick PCR purification kit
(Qiagen) were used for DNA purification. The restriction
enzymes used in this work were from New England Biolabs.
All the DNA ligations were carried out with the Rapid DNA
Ligation kit (Roche). For plasmid maintenance and protein
expression, different antibiotics were used depending on the
strain and plasmid requirements. Antibiotic stock solutions
were prepared, filtered through 0.2 μm, and stored at −20 °C
in the following concentrations: kanamycin, 30 mgmL–1; car-
benicillin, 100 mgmL–1; and chloramphenicol, 10 mgmL–1.
Construction of the pETMFh8 and pETMH vectors
The insertion of the Fh8 tag with the TEV cleavage site into the
pETM10 vector (Table 1) was carried out by DNA ligation of
the NcoI–KpnI digested plasmid and PciI–KpnI digested fh8
PCR product. The pETMH fusion vector was obtained from
the pETM11 backbone (Table 1), performing three PCRs: The
PCR-I inserted part of the H tag (the first 28 nucleotides) after
the His6 tag sequence from the pETM11 plasmid. The PCR-II
inserted part of the H tag (the final 28 nucleotides) before the
TEV cleavage site of the pETM11 plasmid. As the H tag
sequence has only 33 basepairs (bp), specific primers were
designed for the PCR I and II in order to have 23 nucleotides of
the H tag sequence matching in both PCRs. The universal
primers T7 forward and reverse were used in the PCR-III for
amplification of the His6 tag/H tag/TEV site sequence to be
cloned into the pETM11 plasmid. The purified PCR-III prod-
uct and the pETM11 plasmid were digested with XbaI and
XhoI restriction enzymes, and the final pETMH vector was
obtained by ligation of the digested DNAs. E. coli DH5α
competent cells were transformed with the constructed
pETMFh8 and pETMH plasmids, and the obtained clones
were analyzed by colony PCR. The novel pETMFh8 and
pETMH fusion vectors were confirmed by sequencing with
both T7 forward and reverse universal primers.
Cloning of the target genes into pETM vectors
The target genes ypk1_frag, rvs167, spo14_frag, and ypk2
used in this work (Table 2) are synthetic genes previously
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optimized for E. coli expression. All these genes were
inserted into the pETM vectors (Table 3) using the NcoI/
BamHI–XhoI restriction sites, presented at the beginning of
each gene sequence and after the stop codon, respectively.
The frutalin and cp12 genes (Table 2) were modified by
PCR to have the NcoI/BamHI–XhoI restriction sites at the
same positions as the other target genes. A similar primer
designing was used to amplify both frutalin and cp12
sequences as follows: primer forward 5′-TCTATTCC
ATGGGATCC-22 initial nt of the target gene -3′ with the
NcoI restriction site in bold, the BamHI restriction site in
italic and the first 22 nucleotides of each gene underlined,
and primer reverse 5′-AATAGACTCGAG-22 final nt of the
target gene-3′ with the XhoI restriction site in bold and the
final 22 nucleotides of each gene underlined. After ligation
of the digested PCR products and plasmids, E. coli DH5α
competent cells were transformed, and the resulting clones
were analyzed and confirmed as previously mentioned.
Expression strains and culture conditions
Four different expression strains were evaluated in this work:
the E. coli BL21 (DE3) Codon Plus-RIL, the E. coli Rosetta
(DE3) cells, the E. coli Tuner (DE3) strain, and the E. coli
SoluBL21 strain. Competent cells of the four different strains
were prepared and transformed with the constructed fusion
vectors. The resulting clones were confirmed by colony PCR,
and one positive clone was selected for the expression trials.
All the cells were grown in LB media with the appropriate
antibiotics diluted with a factor of 1,000 (see Table 3 for
selection and maintenance of pETM vectors). In this work,
the degradation-resistant carbenicillin was used instead of
ampicillin. Precultures were grown overnight (o/n) at 37 °C
and a dilution factor of 100 was used for inoculation of all
cultures (usually corresponding to a starting OD600nm of 0.02).
Cultures were performed in parallel, using 10 mL of culture
media in 24 deep-well plates (25 mL capacity per well; DIA
Nielsen GmbH&Co. KG, Germany) for small-scale screen-
ings and 500 mL of culture media in 2-L flasks for the scale-
up. Cultures were grown at 37 °C and 200 rpm to a final
OD600nm of 0.4–0.6 before induction. In the small-scale study,
two plates with the same strain and fusion proteins were used
to test different induction conditions: isopropyl-β-D-1-thioga-
lactopyranoside at 0.5 mM, 28 °C and 3 h (first plate) or at
0.2 mM, 18 °C and o/n (second plate). Each 10 mL culture
was divided in two 5-mL cultures. All cells were harvested for
25 min, at 4 °C and 4,500 rpm. Cell pellets from 500 mL
cultures were washed once with 1× phosphate-buffered saline
and collected again by centrifugation. Bacterial pellets were
flash frozen in liquid nitrogen and stored at −20 °C.
Cell lysis
In the small-scale screening, two sonication protocols were
tested using an eight-microtip sonicator or a single-tip son-
icator (G. Heinemann, Germany). For the eight-microtip
lysis, cells from a 5-mL culture pellet were resuspended in
1 mL of lysis buffer [50 mM Tris pH8.0, 250 mM NaCl,
20 mM imidazole buffer supplemented with 1× complete
free EDTA protease inhibitor (Roche), 5 mM MgCl2
(Sigma), 5 μgmL–1 DNAse (Sigma), and 1 mgmL–1 lyso-
zyme (Sigma)] and transferred to a 96-deep-well plate
(2 mL capacity per well) and incubated at room temperature
for 10 min. The plate was placed on ice, and cells were
Table 1 Construction of the pETMFh8 and pETMH expression vectors
Backbone Vector PCR Primers Sequence (5′→3′) Comments
pETM 10 pETMFh8 I Fh8-FWD TCTATTACATGTCCCCTAGTGTTCAAGA
GGTTGAAAAAC
In bold is the PciI restriction enzyme sequence
and underlined is the initial part of the Fh8
tag sequence
Fh8-RV AATAGAGGTACCGGAACCCATGGAGCC
CTGAAAATAAAGATTCTCTGACAAAATCG
AAACGAG
In bold is the KpnI restriction enzyme sequence
and in bold underlined is the NcoI restriction
enzyme sequence. In italic bold is the TEV
recognition cleavage site and underlined is
the final part of the Fh8 tag sequence
pETM 11 pETMH I T7-FWD TAATACGACTCACTATAGGG Underlined are the first 28 nucleotides of the
H tag sequence. In bold underlined are the
23 common nucleotides used in both I and II
PCRs. In italic bold is the His6 tag sequence
of the pETM11 plasmid
Htag-RV GTTTTTCAACCTCTTGAACACTAGGCAT
GTGATGGTGATGGTGATGTTTC
II Htag-FWD TAGTGTTCAAGAGGTTGAAAAACTCCTT
GAGAATCTTTATTTTCAGGGC
Underlined are the final 28 nucleotides of the
H tag sequence. In bold underlined are the
23 common nucleotides used in both I and II
PCRs. In italic bold is the TEV recognition
cleavage site of the pETM11 plasmid
T7-RV GCTAGTTATTGCTCAGCGG
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further lysed by sonication. The lysis efficiency was im-
proved by adding 400 μL of 0.5 mm beads to each well. The
96-deep-well plates were then centrifuged at 4,000 rpm,
4 °C for 45 min, and the supernatant fraction was collected
to a new 96-deep-well plate. For the single-tip lysis, 5-mL
cell pellets were resuspended in 1 mL of lysis buffer and
transferred to a 2-mL tube containing 0.5 mm beads. After
10 min incubation at room temperature, bacterial cells were
lysed by sonication, and 2-mL tubes were centrifuged at
13,000 rpm at 4 °C for 25 min. The supernatant fractions
were transferred to new 2-mL tubes. In the scale-up experi-
ments, cell pellets were thawed and resuspended in 10 mL
of lysis buffer. After incubation at room temperature for
10 min, cells were sonicated (Branson Sonifier 250, G.
Heinemann, Germany), and the soluble fraction was re-
moved from the insoluble cell debris by ultracentrifugation
at 40,000 rpm, 4 °C for 30 min. In all the experiments,
aliquots of total lysates and supernatant samples were taken
and prepared to be analyzed by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE).
Protein purification and tag removal
The selected fusion proteins were purified by nickel affinity
chromatography using a spin protocol with Ni-NTA slurry
(Qiagen) for the small-scale screening or a semi-automated
system, in which 100 μL prepacked Ni-NTA superflow col-
umns (Robot Columns, Atoll GmbH, Germany) were set on a
96-well plate matrix, for the scale-up experiments. Both puri-
fications were conducted according to manufacturer’s instruc-
tions, using 50 mM Tris pH 8.0, 250 mM NaCl with 20 mM
imidazole as running and washing buffer, and with 300 mM
imidazole for the elution buffer. The collected fractions were
analyzed by SDS-PAGE, and the total protein content of robot
eluted samples was also estimated by Bradford assay.
For tag removal, the selected and purified proteins were
digested with the TEV protease. After digestion, aliquots were
taken, and samples were centrifuged at 13,000 rpm for 10 min
at 4 °C. The cleaved proteins were then purified from the
fusion tags and proteases by nickel affinity chromatography
using the same above-mentioned protocol. The collected sam-
ples were prepared to be analyzed by SDS-PAGE.
Protein expression and solubility evaluation
The expression and solubility evaluation was conducted
using a score of 0, 1, 2, and 3, based on the expected
soluble protein production yields obtained after the pu-
rification of 1-L cultures (Berrow et al. 2006; Bird
2011). The score 0 corresponds to no expression/soluble
protein, a score of 1 was given to the soluble expres-
sions that are expected to yield <0.5 mg, the score of 2
indicates a soluble expression yield between 0.5 andTa
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5 mg, and a score of 3 specifies the soluble expressions
with an expected yield >5 mg. The soluble expression
results were estimated from the SDS-PAGE analysis of
the eluted fractions from nickel column and also from
the respective supernatant fractions, according to the
following equations:
Protein soluble expression ¼ number of scores 1; 2; and 3 for the tested protein
number of fusion tags tested
ð1Þ
Tag soluble expression ¼ number of soluble proteins fused to the tagwith scores 1; 2; and 3
number of total proteins tested
ð2Þ
Tag soluble score 2þ 3 ¼ number of soluble proteins fused to the tag with scores 2 and 3
number of total proteins tested
ð3Þ
The total expression results were estimated from the
SDS-PAGE analysis of the total lysate fractions using the
same scores 0–3, but here for the expected expression
yields, as follows:
Tag total expression ¼ number of expressed proteins with scores 1; 2; and 3
number of total proteins tested
ð4Þ
Results
The novel pETMFh8 and pETMH fusion vectors
The fusion tags in this study, Fh8 and H tags, were inserted
into the pETM vector series (Dummler et al. 2005) resulting
into two novel expression vectors: the pETMFh8tag and
pETMHtag (see Online Resource 1). The pETMFh8tag vector
was constructed using the pETM10 backbone and the
pETMHtag vector used the pETM11 backbone (Table 1).
Both new vectors share common features with the rest of the
pETM vectors used in this work (Table 3): They have similar
multiple cloning sites (MCS) suitable for direct subcloning of
the target genes; two His6 tag sequences, one placed at the N-
terminal of the fusion partner and the other after the MCS; and
a TEV protease cleavage site between the fusion partner and
the MCS. The novel fusion plasmids are kanamycin resistant.
In this work, only the N-terminal His6 tag was used for protein
Table 3 Features of expression vectors and properties of the tags used in this work
Expression
vectors (pETM)
Fusion protein Tag size
(aa)
pI MW tag
(Da)
GRAVY Promoter Selection Protease
cleavage site
11 (His) MK-His6-TEV(ENLYFQ↓G)AMGS-Target 29 6.24 3,420 −1.09 T7/lac kan TEV
20 (Trx) M-Trx- -His6-TEV(ENLYFQ↓G)AMGS-Target 136 5.66 14,673 −0.189 T7/lac amp TEV
30 (GST) MK-His6-GST-TEV(ENLYFQ↓G)AMGS-Target 254 6.31 29,264 −0.446 T7/lac kan TEV
41 (MBP) MK-His6- MBP-TEV(ENLYFQ↓G)AMGS-Target 404 5.49 44,549 −0.462 T7/lac kan TEV
60 (NusA) M-NusA- His6-TEV(ENLYFQ↓G)AMGS-Target 519 4.63 57,383 −0.306 T7/lac kan TEV
SUMO MK-His6-TEV(ENLYFQG)-SUMO-TGGS-Target 108 6.02 12,453 −0.882 T7/lac kan SUMO
H MK-His6-Htag-TEV(ENLYFQ↓G)AMGS-Target 30 6.56 3,553 −0.773 T7/lac kan TEV
Fh8 MK-His6-Fh8tag-TEV(ENLYFQ↓G)SMGS-Target 90 6.43 10,146 −0.780 T7/lac kan TEV
aa aminoacids, pI isoelectric point, MW molecular weight, Da Dalton, GRAVY grand average of hydropathicity
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purification. In the pETM series, the Fh8 and H tags have only
10 and 3.6 kDa, respectively (Table 3). Both new fusion tags
have lower molecular weights than the studied fusion tags,
even compared to the low molecular weight tags such as
SUMO (12.5 kDa) and Trx (14.7 kDa). The analysis of fusion
tags features (Table 3) shows that Fh8 and H tags have
identical isoelectric points, which are also similar to the GST
or SUMO values. The Grand average of hydropathicity
(GRAVY) shows a predominantly hydrophilic nature of the
fusion tags (all the GRAVYvalues are negative). The Fh8 and
H tags along with SUMO and His tags present the highest
hydrophilic character.
Cloning of target proteins into the pETM expression vectors
The synthetic genes used in this work (Table 2) were cloned
in parallel into the pETM vectors using the same restriction
enzymes for all the constructions: All the pETM vectors
received NcoI–XhoI digested target genes with the exception
for pETMSUMO, which received BamHI–XhoI digested
inserts. This strategy allowed a rapid and easy cloning
procedure and a successful cloning rate of 98 %. From the
48 fusion genes to be constructed, only the cloning of the
ypk1_frag into the pETMHtag vector was not successful, as
confirmed by sequencing at the GATC (Germany). The six
target proteins used in this work were selected regarding
their previous difficulty of expression in soluble form in E.
coli. Four of these proteins (two full length, RVS167 and
YPK2; and two truncated proteins, SPO14 and YPK1) are
found in the yeast Saccharomyces cerevisiae and were cho-
sen due to the little/absent soluble expression in E. coli
obtained when formerly fused to human SUMO3 tag (data
not shown). The other two target proteins [the truncated
CP12 derived from the Cryptosporidium parvum parasite
(Yao et al. 2007) and the lectin Frutalin from the plant seed
Artocarpus incisa (Oliveira et al. 2009, 2011)] were previ-
ously expressed as full lengths in E. coli presenting poor
solubility. The selected target proteins have different loca-
tions and functions or applications, and they also differ in
size: the smallest target protein used in this work (a truncat-
ed form of the CP12 protein lacking its transmembrane
region) has only 71 amino acids, and the largest one,
YPK2, has approximately 700 amino acids. All the target
proteins have low cysteine content, and they range from a
slight to moderate hydrophilic nature (Table 2).
Small-scale screening: selection of the expression strain
and culture conditions
Figure 1 presents the small-scale comparison of the soluble
expression for the different strains, fusion tags, and target
proteins. Figure 1a presents the SDS-PAGE analysis of super-
natant samples from the selected strains, using the two
induction conditions tested. Figure 1b result from the analysis
of scores 1–3 in supernatant fractions obtained from the eight-
microtip sonication protocol, using Eq. 1. For all the four
strains, the number of soluble expressed proteins using the
Fh8 tag was similar to the number obtained with the MBP or
NusA tags, and higher than the number obtained using the Trx
and GST tags. Proteins fused to the H tag and His6 tag
presented the lowest soluble expression along with proteins
fused to SUMO, whose insolubility was previously evaluated
for four of the six targets. The solubility of SUMO–Frutalin
fusion was difficult to evaluate, as observed by the small
protein content in lanes 12 and 13 of Fig. 1a. SUMO-CP12
and SUMO-YPK2 fusion proteins presented amounts of sol-
uble protein similar to those of Fh8-CP12 and Fh8-YPK2,
respectively, as observed in Fig. 1a. CP12 and Frutalin were
soluble expressed within the highest number of fusion tags,
and this result was observed among all the four strains used in
this work (Fig. 1b). This small-scale screening resulted in the
following rank of the fusion tags for protein solubility: MBP>
NusA>Fh8∼Trx>GST∼H>His. According to the obtained
results in Fig. 1, the E. coli BL21 (DE3) Codon Plus-RIL
strain was established for the expression of the fusions with
CP12, RVS167, and YPK2 target proteins, and the E. coli
Rosetta (DE3) strain was selected for the expression of the
fusions with Frutalin and truncated SPO14. Finally, fusions
with the truncated YPK1 protein were later expressed using
the E. coli Tuner (DE3) strain. The E. coli SoluBL21 strain
was not used further in this study. Regarding the two different
culture conditions tested, the overnight induction condition
presented the highest level of soluble expression for five of the
six target proteins. The 3-h induction condition was only the
best option for the fusions with CP12 target protein. All the
soluble expressed fusion proteins presented a molecular
weight identical to the expected size (see Online Resource
2). SUMO fusions migrated on SDS-PAGE with a molecular
weight of 3 kDa higher than the expected, which is also known
from previous publications (Marblestone et al. 2006).
Small-scale expression and solubility results: validation
For each target protein, four to six tags were selected to
continue with the small-scale screening and to validate the
initial solubility results. Table 4 summarizes the selected
fusion proteins for the direct comparison of commonly used
fusion tags and Fh8 tag. Figure 2 presents the SDS-PAGE
analysis of the total lysate and supernatant fractions of the
selected fusion proteins that were obtained from the bacte-
rial lysis with a single microtip sonication. These samples
were also scored 0–3 (see Online Resource 3). As observed,
the MBP, NusA, and Trx fusions resulted in higher total
expression than the Fh8 fusions. The Fh8 fusions resulted in
a total expression identical to the H and His fusions. To
further validate the solubility screening, the supernatant
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samples presented in Fig. 2 were processed by nickel affin-
ity small-scale purification. Results from this analysis were
evaluated by SDS-PAGE and also scored 0–3 (Fig. 3a, b,
respectively). The MBP and NusA fusion proteins improved
the solubility of a higher number of proteins than the Fh8
tag (groups I, II and III; Table 4). Proteins fused to MBP and
NusA tags were, however, obtained in lower soluble
amounts than those estimated before purification (see
Online Resource 3e). For the Fh8 fusion proteins, no differ-
ences were observed before (see Online Resource 3) and
after purification. The same observation is valid for the
fusions of the comparison groups IV, V, and VI of Table 4
(see Online Resource 3 for the scoring results before purifi-
cation). SUMO and Fh8 tags presented identical soluble
amounts for CP12 and YPK2 proteins (Table 4, group V).
The Fh8 fusions presented higher solubility than the H
a
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b
Fig. 1 Comparison of fusion protein soluble expression using different
E. coli strains: small-scale screening evaluation of the supernatant frac-
tions from the cell lysis with the eight-tip sonicator. a SDS-PAGE of the
supernatant samples from the two induction conditions tested. The 3-
h induction samples were loaded aside with the o/n induction, according
to the following fusion tags order: His–Trx–GST–MBP–NusA–SUMO–
H–Fh8tag. The YPK1 gel follows the same order except for the H tag
(which is not available with this target protein). The in-house protein
marker was used for this analysis. Arrows indicate the expected molecular
weights for all fusion proteins following the fusion tags order loaded on
the gels. b Soluble expression (scores 1–3) per target protein with differ-
ent strains. Plotted values were estimated by Eq. 1
Appl Microbiol Biotechnol (2013) 97:6779–6791 6785
fusions. Interestingly, when directly compared using the
CP12 and Frutalin proteins (Table 4, group VI), Fh8 fusion
proteins achieved the highest solubility, identical to proteins
fused with NusA tag. In general, the rank of the fusion tags
obtained in this analysis for protein solubility after purifica-
tion was identical to the previously observed, with the NusA
and the MBP on the top of solubility tags, followed by the
Fh8 and Trx tags. The H tag increased the E. coli protein
expression identical to the Fh8 tag but did not improve
protein solubility. The target protein SPO14 was not used
further in this work as no soluble protein was detected in the
small-scale expression and purification screenings.
Scale-up protein processing: evaluation of the fusion
proteins solubility before and after tag removal
Figure 4 presents the SDS-PAGE results obtained for the
scale-up screening. All the fusion proteins were successfully
expressed in soluble form at the expected molecular weights
(see Online Resource 2) in E. coli 500 mL cultures.
Bradford estimations were also conducted to support the
SDS-PAGE analysis (see Online Resources 4 and 5).
Making a wide comparison based on the group VI
(Table 4), the Fh8 fusions resulted in similar soluble
amounts as the Trx and NusA fusions, corroborating the
small-scale screening results. After tag removal, the Fh8
fusions performed better than the NusA or MBP fusions,
resulting in higher soluble amounts of the cleaved proteins.
A case by case comparison established that NusA, Trx, and
Fh8 fusions improved the Frutalin soluble expression fol-
lowing this order: NusA∼Fh8>Trx>His>Htag (Fig. 4a).
Interestingly, after tag removal, the cleaved and purified
Frutalin (17 kDa) from the Fh8 and Trx fusions presented
higher protein amounts than the Frutalin cleaved from the
NusA fusion protein. A similar result was obtained for the
expression of CP12 target protein with the different fusion
tags (Fig. 4b). The Fh8-CP12 fusion protein achieved sim-
ilar, but slightly lower, soluble amounts than the Trx and
NusA fusions. After tag removal, the cleaved CP12 protein
(8 kDa) from Fh8 fusion presented higher soluble amounts
Table 4 Selection of fusion
proteins for small-scale screen-
ing—comparison groups
Comparison group no. Selected fusion tags Target proteins
I His, MBP, Fh8 Frutalin, RVS167, SPO14, YPK1, YPK2
II His, NusA. Fh8 CP12, Frutalin, RVS167, YPK1
III His, MBP, NusA, Fh8 Frutalin, RVS167, YPK1
IV His, Htag, Fh8 CP12, Frutalin, YPK2
V His, SUMO, Fh8 CP12, YPK2
VI His, Trx, NusA, H, Fh8 CP12, Frutalin
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His              MBP Trx
NusA Fh8           H
His              Trx           NusA
SUMO        Fh8           H
Fig. 2 SDS-PAGE analysis of the total lysate and supernatant samples
from the selected fusion proteins in the second small-scale screening.
Samples were obtained after cell lysis with a single tip sonication. Gels
were loaded with each total lysate sample aside with the respective
supernatant (soluble) sample. Arrows indicate the expected molecular
weights for all fusion proteins following the fusion tags order loaded
on the gels
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Fig. 3 Fusion proteins nickel-affinity purification: small-scale pro-
cessing. a SDS-PAGE analysis of nickel affinity purifications. Gels
were loaded following this sequence: supernatant fraction–flow
through–washing step–elution 1–elution 2. Arrows indicate the loca-
tion of fusion proteins at the observed/expected molecular weight.
b Soluble expression comparison per fusion tag of the different groups
of target proteins. The “tag soluble expression” refers to the percentage
of proteins with scores 1–3, estimated by Eq. 2. The “tag soluble score
2+3” refers to the percentage of proteins with scores 2 and 3, estimated
by Eq. 3
Appl Microbiol Biotechnol (2013) 97:6779–6791 6787
than the NusA-containing cleaved protein. The RVS167
(Fig. 4a) and YPK1 (Fig. 4c) target proteins were obtained
in higher soluble amounts when fused with the NusA tag
than with the Fh8 tag. After tag removal, the cleaved YPK1
protein (35 kDa) from the NusA fusion yielded higher
amounts than the one from the Fh8 fusion (Fig. 4c). For
the RVS167 tag removal experiment, only the NusA fusion
was tested. The SDS-PAGE bands resulting from this diges-
tion (Fig. 4a) were difficult to distinguish as the molecular
weight expected for the cleaved RVS167 (54 kDa) was close
to the one (57 kDa) expected for the NusA. The YPK2 target
protein, of which the soluble expression was not easy to
assess in the small-scale screening, presented interesting
results in the scale-up experiments. Upon scale-up, this
target protein revealed to be highly soluble expressed when
fused to the Fh8 tag, out-performing the MBP fusion pro-
tein. The final cleaved YPK2 (78 kDa) from the Fh8 fusion
was obtained in 2.3-fold higher amount than the cleaved
protein from the MBP fusion.
Discussion
In this work, a novel fusion system for soluble protein over-
expression in E. coli—the Fh8 tag (8 kDa) and H tag
(1 kDa)—is presented and compared to the traditional fusion
a
b
c
His Trx NusA H Fh8 M NusA H Fh8 1  2  3   4  5 M 1  2   3 4  1  2  3  4 5 1    2   3   4   5 1    2    3  4  5 M
*
* * *
*
1 2 3 4 5 M  His      Fh8 H        M
NusA MBP Fh8
[NusA      Fh8] MBP-YPK2 Fh8-YPK2[YPK1] YPK2
1 2  3 4  5   1 2  3  4  5 M 1  2  3 4  5
*
*
*
*
*
*
*
*
*
[Frutalin] RVS167 [His         Trx       NusA         Fh8] NusA-RVS167
1 2 3 4 5 M 1 2 3  4 5  M His Trx NusA H Fh8
His Trx         NusA        H           Fh8CP12
1  2 3 4  5 M 1 2 3  4 5   1  2  3 4 5
Fig. 4 Fusion proteins nickel-affinity purification and tag removal:
semi-automated processing. a Frutalin (in brackets) and RVS167 5th
eluted fractions and corresponding samples before/after TEV digestion
and after cleaved protein purification. b CP12 5th eluted fractions and
corresponding samples before/after TEV digestion and after cleaved
protein purification. c YPK1 (in brackets) and YPK2 4th eluted frac-
tions and corresponding samples before/after TEV digestion and after
cleaved protein purification. M In-house protein marker; 1–3 samples
before TEV, after TEV, and after TEV plus centrifugation; 4 and 5 flow
through and washing samples from the purification of the cleaved
proteins. The right arrowhead marks show the Fh8-fusion proteins
on the gel. Arrows indicate the expected molecular weight of cleaved
proteins. Asterisk position the fusion tags after TEV digestion
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partners using a screening methodology. For the soluble pro-
tein expression screening, both Fh8 and H partners were
inserted into the pETM vector series (Dummler et al. 2005).
Using the same backbone, promoter, and cloning procedures,
it was possible to achieve a systematic and consistent com-
parative analysis of the different solubility tags. All the select-
ed pETM vectors are identical, differing only at the N-
terminal fusion partners. Here, any differences found in target
protein expression levels will probably be caused by the
fusion partners sequence specific properties. The N-terminal
position of the fusion partners seems to be a good option for
optimal protein expression compared to the C-terminal posi-
tion (not tested in this study) as it will allow the fusion partner
to be translated first, providing time for the correct folding of
the target proteins (Dyson et al. 2004). The Trx, GST, MBP,
and NusA fusion partners were used in the screening compar-
ison due to their known expression and solubility enhancing
features and also because they are the most widely used fusion
partners for recombinant protein production. The SUMO part-
ner (Marblestone et al. 2006; Malakhov et al. 2004) was
determinant for the selection of four target proteins, which
were previously insoluble with this tag. Nevertheless, it was
also included in this study to evaluate its solubility effect
among the other fusion tags in the Frutalin and CP12 target
proteins. The solubility of SUMO–Frutalin fusion was, how-
ever, not well evaluated probably due to a technical problem
during the eight-tip sonication lysis, in which the ultrasound
may not be equally distributed among the eight tips, resulting
in the lower protein content observed in the small-scale
screening of this fusion protein. The first expression and
solubility comparisons between proteins fused to the Fh8
and H fusion partners and to the other tags were conducted
in a small-scale screening, using qualitative SDS-PAGE and
Bradford analyses. The small-scale screening strategy already
proved to be a reliable tool for the comparison and selection of
soluble proteins among different constructs, and it is a useful
indicator of the expected protein production amounts upon
scale-up expressions (Berrow et al. 2006; Dummler et al.
2005). Gel bands of fusion proteins were scored according
to the 0–3 scale used by Berrow et al. (2006) and Bird (2011).
In this study, scores 1–3 were given to an increased protein
solubility level (for purified and supernatant samples) and
were also used to estimate the total expression levels of fusion
proteins. At a small-scale screening, scores 2 and 3 proved to
be more consistent solubility predictors than the score 1,
which may not represent a proper soluble expression in
scale-up cultures (Bird 2011). Thus, three different evalua-
tions were conducted here: the comparison of total expression
(scores 1–3), the comparison of soluble expression (scores 1–
3) and the comparison of soluble proteins with scores 2 and 3.
The small-scale comparisons showed that the Fh8 fusion
partner stands among the well-described best fusion partners,
MBP, NusA, and Trx, for soluble protein expression (Kohl et
al. 2008; Nallamsetty andWaugh 2006). Interestingly, the Fh8
fusions presented lower total expression levels than these
known tags. This difference in the expression levels may
explain the better solubility results of some proteins when
fused to the Fh8 tag. In spite of presenting higher total ex-
pression levels than the His tag fusions and identical to the
Fh8 fusions, the H tag performed poorly in the protein solu-
bility analysis, not working as solubility enhancing tag in E.
coli. The GST fusion partner was previously evaluated as a
relatively poor tag in several comparison studies (Bird 2011;
Hammarstrom 2006; Ohana et al. 2009), which was con-
firmed also in our study. In addition to the fusion partners
comparison, four different expression strains and two induc-
tion conditions were also tested in the small-scale screening.
The best induction condition revealed to be correlated with the
molecular weight of target proteins. Proteins with high mo-
lecular weights performed better at lower induction temper-
atures, in contrast to the CP12 protein, the smallest molecular
weight target studied, which performed better with an induc-
tion temperature of 30 °C for 3 h. In fact, a lower induction
temperature will slow down the protein expression rate, pro-
moting a less stressful environment to the cell for protein
production. A slow translation rate may improve the correct
folding of higher molecular weight proteins and consequently
their solubility (Berrow et al. 2006; Pacheco et al. 2012;
Sorensen and Mortensen 2005; Terpe 2006). Most of the
fusion proteins presented higher solubility when expressed
in E. coli strains engineered with extra copies of rare codons
[BL21 (DE3) Codon Plus-RIL and Rosetta (DE3)], thus con-
firming the importance of protein expression optimization via
its host cell (Makino et al. 2011; Pacheco et al. 2012; Vernet et
al. 2011). The small-scale screening was reproducible as
shown by the comparison screenings before and after protein
purification, which is essential to assess the real protein solu-
bility among the different fusion tags (Dummler et al. 2005).
In general, results from the scale-up analysis were consistent
with the small-scale screening: The Fh8 fusion partner is
among the best expression and solubility enhancing tags (as
NusA and Trx). The YPK2 target (not successfully expressed
in small-scale screening) was an exception, resulting in an
improved solubility when fused to the Fh8 tag at the scale-up
expression. Thus, when conducting a small-scale high
throughput analysis, one must be aware of the balance be-
tween the loss of some target proteins for scale-up and the gain
in increased number of parallel evaluations (Berrow et al.
2006). The YPK1 and RVS167 target proteins were, effec-
tively, difficult to express as soluble proteins even using the
NusA or Fh8 tags. In both screening methodologies, the
position of the His6 tag did not interfere with the expression
and purification results since fusion constructs with the affin-
ity tag in the middle of the fusion partner and the TEV
cleavage site (NusA and Trx) performed as well as the fusion
constructs with the affinity tag in the N-terminus (Trx, MBP
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and Fh8). In both small-scale and scale-up experiments, fusion
partners were removed using the TEV protease, leaving a
glycine residue in the N-terminal of target proteins. The
Fh8-derived target proteins presented similar final solubility
as the Trx-derived ones and, curiously, performed better than
the target proteins cleaved from NusA and MBP fusions. In
fact, larger fusion partners are good solubilizers, but their large
size can lead to an overoptimistic evaluation of protein solu-
bility and yield (Dyson et al. 2004; Hammarstrom 2006;
Kapust and Waugh 1999; Shih et al. 2002), as shown by the
different solubility results before and upon tag removal.
Looking among the solubility fusion partners used in this work,
the Fh8 tag has the lowest contribution on the final size of the
fusion protein (see Online Resource 6), which can explain the
apparent lower solubility of Fh8 fusions in comparison to
NusA orMBP fusions. In this context, the YPK2 target protein
was again a particular case, in which the solubility effect of the
Fh8 tag over the MBP tag was noticed in both “before” and
“after” tag removal experiments. The SDS-PAGE and
Bradford screening methodology used for the assessment of
soluble expression before and after protein purification as well
as upon tag removal is protein dependent, requiring a calibra-
tion for each protein (Hammarstrom 2006). Even so, a good
agreement between the two methodologies was obtained, in-
dicating that it can be used to predict and compare the protein
soluble expression levels among different constructs.
The novel Fh8 fusion partner presented in this work
revealed to be an effective tool for the improvement of
protein solubility in E. coli. The conducted study pointed
that (1) there is no “the best tag” for protein soluble expres-
sion, so multiple tags need to be tested with different pro-
teins; (2) larger tags usually result in higher production
yields, but these can lead to overestimation of the amount
of soluble protein; (3) the smaller the size of the fusion tag,
the easier it is to assess the solubility of the target protein.
Thus, the Fh8 tag is an excellent candidate for testing
expression and solubility next to the other well-known fu-
sion tags. Its low molecular weight and its solubility en-
hancing effect make Fh8 an advantageous option compared
to larger fusion tags for soluble protein production in E. coli.
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